The DOI matches its Crossref record; 60 of the 60 references it cites were found in a registry or an index.
State-Transition Modeling: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force–3
Abstract
State-transition modeling (STM) is an intuitive, flexible, and transparent approach of computer-based decision-analytic modeling, including both Markov model cohort simulation as well as individual-based (first-order Monte Carlo) microsimulation. Conceptualizing a decision problem in terms of a set of (health) states and transitions among these states, STM is one of the most widespread modeling techniques in clinical decision analysis, health technology assessment, and health-economic evaluation. STMs have been used in many different populations and diseases, and their applications range from personalized health care strategies to public health programs. Most frequently, state-transition models are used in the evaluation of risk factor interventions, screening, diagnostic procedures, treatment strategies, and disease management programs.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Another approach is to use within-cycle corrections (WCC).2,22”
From An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example (2023) · cites this paper as [2]
In the citing paper
“cSTMs are usually computationally less demanding than individual-based state-transition models (iSTMs), providing the ability to conduct PSA and value-of-information (VOI) analyses that otherwise might not be computationally feasible with iSTMs.2”
From An Introductory Tutorial on Cohort State-Transition Models in R Using a Cost-Effectiveness Analysis Example (2023) · cites this paper as [2]
Citations
Cites
GRADE guidelines: 3. Rating the quality of evidence
Balshem, H., Helfand, M., Schünemann, H. J., Oxman, A. D., Kunz, R., Brozek, J., Vist, G. E., Falck-Ytter, Y., Meerpohl, J., & Norris, S. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.015 · Cited by 8,285
Puterman, M. L. (1994) · Wiley series in probability and statistics · doi:10.1002/9780470316887 · Cited by 6,057
GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology
Guyatt, G. H., Oxman, A. D., Schünemann, H. J., Tugwell, P., & Knottnerus, A. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.09.011 · Cited by 3,094
Markov Models in Medical Decision Making: A Practical Guide
Sonnenberg, F. A., & Beck, J. R. (1993) · Medical Decision Making · doi:10.1177/0272989x9301300409 · Cited by 2,419
The Markov process in medical prognosis
Beck, J. R., & Pauker, S. G. (1983) · Medical Decision Making · doi:10.1177/0272989x8300300403 · Cited by 957
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12458348 · Cited by 887
Model Transparency and Validation
Eddy, D. M., Hollingworth, W., Jaime, J., Tsevat, J., McDonald, K. M., & Wong, J. B. (2012) · Medical Decision Making · doi:10.1177/0272989x12454579 · Cited by 803
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.014 · Cited by 711
Clarke, P. M., Gray, A. M., Briggs, A., Farmer, A. J., Fenn, P., Stevens, R. J., Matthews, D. R., Stratton, I. M., Holman, R. R., & on behalf of the UK Prospective Diabetes Study (UKPDS) Group (2004) · Diabetologia · doi:10.1007/s00125-004-1527-z · Cited by 615
Cost-Effectiveness of Screening for HIV in the Era of Highly Active Antiretroviral Therapy
Sanders, G. D., Bayoumi, A. M., H, V. S. M. P., Bilir, S. P., Neukermans, C. P., Rydzak, C. E., Douglass, L. R., Lazzeroni, L. C., Holodniy, M., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa042657 · Cited by 603
Self-citationZauber, A. G., Lansdorp‐Vogelaar, I., Knudsen, A. B., Wilschut, J. A., van Ballegooijen, M., & Kuntz, K. M. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-149-9-200811040-00244 · Cited by 580
Self-citationCost-Effectiveness of Implantable Cardioverter–Defibrillators
Sanders, G. D., Hlatky, M. A., & Owens, D. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmsa051989 · Cited by 543
Self-citationCaro, J. J., Briggs, A. H., Siebert, U., & Kuntz, K. M. (2012) · Medical Decision Making · doi:10.1177/0272989x12454577 · Cited by 520
Self-citationOwens, D. K., Lohr, K. N., Atkins, D., Treadwell, J. R., Reston, J. T., Bass, E. B., Chang, S., & Helfand, M. (2010) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2009.03.009 · Cited by 513
Self-citationDecision Making in Health and Medicine: Integrating Evidence and Values
Hunink, M. G. M., Weinstein, M. C., Wittenberg, E., Drummond, M. F., Pliskin, J. S., Wong, J. B., & Glasziou, P. P. (2014) · doi:10.1017/cbo9781139506779 · Cited by 425 · cited 1×
“, second myocardial infarction).(12) Other modeling techniques are also suitable for these situations (e.”
BackgroundRoberts, M. S., Russell, L. B., Paltiel, A. D., Chambers, M. R., McEwan, P. C., & Krahn, M. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12454941 · Cited by 391
Modeling Using Discrete Event Simulation
Karnon, J. D., Stahl, J. E., Brennan, A., Caro, J. J., Mar, J., & Möller, J. (2012) · Medical Decision Making · doi:10.1177/0272989x12455462 · Cited by 344
Cox, E., Martin, B. C., Van Staa, T., Garbe, E., Siebert, U., & Johnson, M. L. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00601.x · Cited by 307
Self-citationJohnson, M. L., Crown, W., Martin, B. C., Dormuth, C. R., & Siebert, U. (2009) · Value in Health · doi:10.1111/j.1524-4733.2009.00602.x · Cited by 285
Self-citationMarkov decision processes: a tool for sequential decision making under uncertainty
Alagoz, O., Hsu, H., Schaefer, A. J., & Roberts, M. S. (2010) · Medical Decision Making · doi:10.1177/0272989x09353194 · Cited by 266
The Cost-effectiveness of Preventing AIDS-Related Opportunistic Infections
Freedberg, K. A. (1998) · JAMA · doi:10.1001/jama.279.2.130 · Cited by 248
Cost-Effectiveness of Sirolimus-Eluting Stents for Treatment of Complex Coronary Stenoses
Cohen, D. J., Bakhai, A., Shi, C., Githiora, L., Lavelle, T. A., Berezin, R. H., Leon, M. B., Moses, J. W., Carrozza, J. P., Zidar, J. P., et al. (2004) · Circulation · doi:10.1161/01.cir.0000136821.99814.43 · Cited by 234
Self-citationDecision Making in Health and Medicine: Integrating Evidence and Values
Ulahannan, T. J. (2002) · Journal of the Royal Society of Medicine · doi:10.1177/014107680209500220 · Cited by 232
Patient-specific decisions about hormone replacement therapy in postmenopausal women
Col, N. F. (1997) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1997.03540380054031 · Cited by 229
Pitman, R., Fisman, D. N., Zaric, G. S., Postma, M. J., Kretzschmar, M., Edmunds, J., & Brisson, M. (2012) · Value in Health · doi:10.1016/j.jval.2012.06.011 · Cited by 223
Recent developments in decision-analytic modelling for economic evaluation
Weinstein, M. C. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624110-00002 · Cited by 220
Screening for Cancer: Theory, Analysis, and Design.
Dubin, N., & Eddy, D. M. (1984) · Journal of the American Statistical Association · doi:10.2307/2288758 · Cited by 218
Determining Transition Probabilities
Miller, D. K., & Homan, S. M. (1994) · Medical Decision Making · doi:10.1177/0272989x9401400107 · Cited by 197
Pharmacoeconomic Analyses Using Discrete Event Simulation
Caro, J. J. (2005) · PharmacoEconomics · doi:10.2165/00019053-200523040-00003 · Cited by 191
When should decision-analytic modeling be used in the economic evaluation of health care?
Siebert, U. (2003) · The European Journal of Health Economics · doi:10.1007/s10198-003-0205-2 · Cited by 181
Self-citationCost-Effectiveness of Alternative Management Strategies for Patients with Solitary Pulmonary Nodules
Gould, M. K., Sanders, G. D., Barnett, P. G., Rydzak, C. E., Maclean, C. C., McClellan, M., & Owens, D. K. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-138-9-200305060-00009 · Cited by 172
Self-citationPitman, R., Fisman, D. N., Zaric, G. S., Postma, M. J., Kretzschmar, M., Edmunds, J., & Brisson, M. (2012) · Medical Decision Making · doi:10.1177/0272989x12454578 · Cited by 151
Radiation-Related Cancer Risks From CT Colonography Screening: A Risk-Benefit Analysis
de González, A. B., Kim, K. P., Knudsen, A. B., Lansdorp‐Vogelaar, I., Rutter, C. M., Smith‐Bindman, R., Yee, J., Kuntz, K. M., van Ballegooijen, M., Zauber, A. G., et al. (2011) · American Journal of Roentgenology · doi:10.2214/ajr.10.4907 · Cited by 117
Self-citationUncertainty and patient heterogeneity in medical decision models
Groot Koerkamp, B., Weinstein, M. C., Stijnen, T., Heijenbrok-Kal, M. H., & Hunink, M. G. M. (2010) · Medical Decision Making · doi:10.1177/0272989x09342277 · Cited by 105
A policy model to evaluate the benefits, risks and costs of warfarin pharmacogenomic testing
Meckley, L. M., Gudgeon, J. M., Anderson, J. L., Williams, M. S., & Veenstra, D. L. (2010) · PharmacoEconomics · doi:10.2165/11318240-000000000-00000 · Cited by 97
Decision-analytic modeling to evaluate benefits and harms of medical tests: uses and limitations
Trikalinos, T. A., Siebert, U., & Lau, J. (2009) · Medical Decision Making · doi:10.1177/0272989x09345022 · Cited by 88
Self-citationModelling in economic evaluation
Kuntz, K. M., & Weinstein, M. C. (2001) · Economic Evaluation in Health Care · doi:10.1093/oso/9780192631770.003.0007 · Cited by 87
Self-citationChapter 19: Cost-effectiveness of cervical cancer screening
Goldie, S. J., Kim, J. J., & Myers, E. (2006) · Vaccine · doi:10.1016/j.vaccine.2006.05.114 · Cited by 84
Toward a Peer Review Process for Medical Decision Analysis Models
Sonnenberg, F. A., Roberts, M. S., Tsevat, J., Wong, J. B., Barry, M. J., & KENT, D. L. (1994) · Medical Care · doi:10.1097/00005650-199407001-00005 · Cited by 73
Cost-Effectiveness of HIV Screening in Patients Older than 55 Years of Age
Sanders, G. D., Bayoumi, A. M., Holodniy, M., & Owens, D. K. (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-12-200806170-00002 · Cited by 72
Self-citationLee, J. M., McMahon, P. M., Kong, C. Y., Kopans, D. B., Ryan, P. D., Ozanne, E. M., Halpern, E. F., & Gazelle, G. S. (2010) · Radiology · doi:10.1148/radiol.09091086 · Cited by 68
Lieu, T. A., Gurley, R. J., Lundstrom, R. J., Ray, G. T., FIREMAN, B. H., Weinstein, M. C., & Parmley, W. W. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)00391-4 · Cited by 60
Spielauer, M. (2007) · International Journal of Microsimulation · doi:10.34196/ijm.00005 · Cited by 55
Educated Guesses: Making Policy about Medical Screening Tests
Russell, L. B., & Fund, M. M. (1994) · DigitalGeorgetown (Georgetown University Library) · Cited by 50
Hunink, M. G. M., Kuntz, K. M., Fleischmann, K. E., & Brady, T. J. (1999) · Annals of Internal Medicine · doi:10.7326/0003-4819-131-9-199911020-00008 · Cited by 50
Self-citationLee, J. M., Kopans, D. B., McMahon, P. M., Halpern, E. F., Ryan, P. D., Weinstein, M. C., & Gazelle, G. S. (2008) · Radiology · doi:10.1148/radiol.2463070224 · Cited by 45
Kuntz, K. M., & Goldie, S. J. (2002) · Medical Decision Making · doi:10.1177/0272989x0202200310 · Cited by 43
Self-citationZaric, G. S. (2003) · Medical Decision Making · doi:10.1177/0272989x03256883 · Cited by 43
KUNTZ, K. M., & Goldie, S. J. (2002) · Medical Decision Making · doi:10.1177/02789x02022003004 · Cited by 43
Self-citationSiebert, U., Sroczynski, G., & on behalf of the German Hepatitis C Model (GEHMO) Group and the HTA Expert Panel on Hepatitis C (2005) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462305050075 · Cited by 42
Self-citationThe cost-effectiveness of screening for hereditary hemochromatosis in Germany: a remodeling study
Rogowski, W. H. (2009) · Medical Decision Making · doi:10.1177/0272989x08327112 · Cited by 42
Keeping the noise down: common random numbers for disease simulation modeling
Stout, N. K., & Goldie, S. J. (2008) · Health Care Management Science · doi:10.1007/s10729-008-9067-6 · Cited by 40
Cost-effectiveness of primary HPV screening for cervical cancer in Germany—a decision analysis
Sroczynski, G., Schnell-Inderst, P., Mühlberger, N., Lang, K., Aidelsburger, P., Wasem, J., Mittendorf, T., Engel, J., Hillemanns, P., Petry, K. U., et al. (2011) · European Journal of Cancer · doi:10.1016/j.ejca.2011.03.006 · Cited by 40
Self-citationLife expectancy biases in clinical decision modeling
Kuntz, K. M., & Weinstein, M. C. (1995) · Medical Decision Making · doi:10.1177/0272989x9501500209 · Cited by 38
Self-citationGrill, E., Hessel, F., Siebert, U., Schnell-Inderst, P., Kunze, S., Nickisch, A., & Wasem, J. (2005) · BMC Public Health · doi:10.1186/1471-2458-5-12 · Cited by 32
Self-citationDewilde, S., & Anderson, R. (2004) · Medical Decision Making · doi:10.1177/0272989x04268953 · Cited by 29
Educated Guesses: Making Policy about Medical Screening Tests
Kelikowske, K. (1994) · BMJ · doi:10.1136/bmj.309.6955.679 · Cited by 16
Cost-effectiveness of cervical cancer screening.
Goldie, S. J., Kim, J. J., & Myers, E. R. (1983) · PubMed · Cited by 14
Effects of categorizing continuous variables in decision-analytic models
Bentley, T. G. K., Weinstein, M. C., & Kuntz, K. M. (2009) · Medical Decision Making · doi:10.1177/0272989x09340238 · Cited by 13
Self-citationde Mesa, E. G., Hidalgo, I., Christidis, P., Ciscar, J. C., Vegas, E., & Ibarreta, D. (2007) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256252 · Cited by 9
Research works printed but not linked: 2
- Robins JM, 2004, Comparative Quantification of Health Risks: Global and Regional Burden of Disease Attributable to Selected Major Risk Factors. Vol. 1, 2191
- Sonnenberg FA, 1994, Med Care, 32, JS52
Cited by
Sorted by citations
Husereau, D., Drummond, M., Petrou, S., Carswell, C., Moher, D., Greenberg, D., Augustovski, F., Briggs, A. H., Mauskopf, J., & Loder, E. (2013) · Value in Health · doi:10.1016/j.jval.2013.02.002 · Cited by 1,998
Model Transparency and Validation
Eddy, D. M., Hollingworth, W., Jaime, J., Tsevat, J., McDonald, K. M., & Wong, J. B. (2012) · Medical Decision Making · doi:10.1177/0272989x12454579 · Cited by 803
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Medical Decision Making · doi:10.1177/0272989x12458348 · Cited by 887
Briggs, A. H., Weinstein, M. C., Fenwick, E. A. L., Karnon, J., Sculpher, M. J., & Paltiel, A. D. (2012) · Value in Health · doi:10.1016/j.jval.2012.04.014 · Cited by 711
Modeling infectious disease dynamics in the complex landscape of global health
Heesterbeek, H., Anderson, R. M., Andreasen, V., Bansal, S., Angelis, D. D., Dye, C., Eames, K. T. D., Edmunds, W. J., Frost, S. D. W., Funk, S., et al. (2015) · Science · doi:10.1126/science.aaa4339 · Cited by 721
Metadata
- Authors
- Siebert, U., Alagoz, O., Bayoumi, A. M., Jahn, B., Owens, D. K., Cohen, D. J., & Kuntz, K. M.
- Affiliations
- St. Michael's Hospital (CA)
- UMIT–University for Health Sciences, Medical Informatics and Technology,Hall/Tyrol, Austria (US)
- Venue
- Medical Decision Making
- Publisher
- SAGE Publications
- Published
- 2012-09
- Volume
- 32
- Issue
- 5
- Pages
- 690-700
- ISSN
- 0272-989X (ISSN-L)
- 1552-681X
- OpenAlex
- W2132708603
- Cited by
- 348
- References
- 59
- Citations by year
- 2026: 23 · 2025: 23 · 2024: 19 · 2023: 18 · 2022: 28 · 2021: 23 · 2020: 29 · 2019: 25 · 2018: 24 · 2017: 29 · 2016: 25 · 2015: 32 · 2014: 21 · 2013: 19 · 2012: 8
- FWCI
- 61.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Medical Decision Making (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Topics
- Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
- Social Sciences › Decision Sciences › Management Science and Operations Research › Simulation Techniques and Applications
- Physical Sciences › Mathematics › Statistics and Probability › Statistical Methods in Clinical Trials
- Keywords
- state transition modeling, Monte Carlo simulation, clinical decision analysis, health technology assessment, health economic evaluation, health states, risk factor intervention, screening, diagnostic procedures, treatment options, disease management programs
- MeSH terms
- Decision Making, Markov Chains, Models, Theoretical, Cohort Studies, Benchmarking
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
